Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Celgene
Mayo Clinic
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Columbia University
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center